Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: molecular cloning, expression and biological properties

Proceedings of the National Academy of Sciences of the United States of America
Lisa HéronD Bataille

Abstract

Sulfonylureas are a class of drugs commonly used in the management of non-insulin-dependent diabetes mellitus. Their therapeutic action results primarily from their ability to inhibit ATP-sensitive potassium (KATP) channels in the plasma membrane of pancreatic beta cells and thereby stimulate insulin release. A key question is whether an endogenous ligand for the KATP channel exists that is able to mimic the inhibitory effects of sulfonylureas. We describe here the cloning of the cDNA encoding human alpha-endosulfine, a 13-kDa peptide that is a putative candidate for such a role. alpha-Endosulfine is expressed in a wide range of tissues including muscle, brain, and endocrine tissues. The recombinant protein displaces binding of the sulfonylurea [3H]glibenclamide to beta cell membranes, inhibits cloned KATP channel currents, and stimulates insulin secretion. We propose that endosulfine is an endogenous regulator of the KATP channel, which has a key role in the control of insulin release and, more generally, couples cell metabolism to electrical activity.

References

Dec 15, 1992·Biochimica Et Biophysica Acta·S J Ashcroft, F M Ashcroft
Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A Virsolvy-VergineD Bataille
Jan 1, 1990·Cellular Signalling·S J Ashcroft, F M Ashcroft
Jan 1, 1990·Methods in Enzymology·F W StudierJ W Dubendorff
Jan 1, 1989·Progress in Biophysics and Molecular Biology·F M Ashcroft, P Rorsman
Aug 11, 1987·European Journal of Pharmacology·B Lupo, D Bataille
Dec 19, 1988·FEBS Letters·A Virsolvy-VergineD Bataille
May 5, 1986·Journal of Molecular Biology·F W Studier, B A Moffatt
Dec 11, 1981·Science·F Sanger
Jun 25, 1996·Biochemical and Biophysical Research Communications·K PeyrollierD Bataille
May 1, 1997·Neuron·J P ClementJ Bryan
Jan 10, 1998·The Journal of General Physiology·S Shyng, C G Nichols
Jul 31, 1998·Trends in Neurosciences·F M Ashcroft, F M Gribble

❮ Previous
Next ❯

Citations

May 18, 2000·Biochemical and Biophysical Research Communications·K Igarashi, K Kashiwagi
May 14, 1999·Trends in Endocrinology and Metabolism : TEM·M J DunneC Ämmälä
Apr 6, 2002·British Journal of Pharmacology·Anne VirsolvyDominique Bataille
Jan 15, 2002·DNA and Cell Biology·J F LoringR Somogyi
Apr 17, 2004·Kidney International·Jerry YeeBalázs Szamosfalvi
Feb 24, 2000·Archives of Disease in Childhood. Fetal and Neonatal Edition·B GlaserC Junien
Oct 18, 2008·Development·Jessica R Von StetinaDaniela Drummond-Barbosa
Nov 7, 2002·Japanese Journal of Pharmacology·Tetsuro KosugiKazuo Ichihara
May 1, 2010·International Journal of Diabetes in Developing Countries·Satya Vani GuttulaPaturi V Rao
May 11, 2000·Seminars in Perinatology·B Glaser
Jan 1, 1999·Nutritional Neuroscience·D S Roane, J K Bounds
Jan 5, 2000·Biophysical Journal·I H ShrivastavaM S Sansom
Jul 15, 2004·American Journal of Physiology. Endocrinology and Metabolism·Flemming DelaHenrik Galbo
Oct 13, 2006·The EMBO Journal·M Alessandra ViganòRoberto Mantovani
Feb 12, 2008·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Vanessa L Horner, Mariana F Wolfner
Apr 16, 1999·Endocrine Reviews·L Aguilar-Bryan, J Bryan
Jun 18, 2004·The Journal of Pharmacology and Experimental Therapeutics·Kenju ShimomuraMasatomo Mori
Nov 6, 2018·European Journal of Medical Research·Yuejin LiKunmei Gong
Sep 20, 2017·Journal of Neuropathology and Experimental Neurology·Rupal I MehtaJ M Simard
Jan 11, 2017·Acta Neuropathologica Communications·Daniel YsselsteinJean-Christophe Rochet
Nov 1, 2008·Biochemistry·John M BoettcherChad M Rienstra
Jan 24, 2004·Developmental Biology·Daniela Drummond-Barbosa, Allan C Spradling
Aug 5, 2021·The FEBS Journal·Chandan ThapaUlla Pentikäinen
Dec 26, 2001·Chemical Reviews·J B Shabb

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.